RE:RE:RE:RE:“Second mouse gets the cheese “
Correction: " ..These events happening at the same time that BioNTech/Genentech(Roche) initiated a Phase 2 with autogene cevumeran + atezolizumab + chemotherapy compared to the standard of care mFOLFIRINOX in October 2023 ...."